1
Lawrence L Kunz, Richard A Klein, John M Reno, David J Grainger, James C Metcalfe, Peter L Weissberg, Peter G Anderson: Therapeutic inhibitor of vascular smooth muscle cells. NeoRx Corporation, Schwegman Lundberg Woessner & Kluth P A, March 31, 1998: US05733925 (479 worldwide citation)

Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a ce ...


2
Lawrence L Kunz, Richard A Klein, John M Reno: Therapeutic inhibitor of vascular smooth muscle cells. NeoRx Corporation, Schwegman Lundberg Woessner & Kluth P A, November 9, 1999: US05981568 (352 worldwide citation)

Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a ...


3
Lawrence L Kunz, Richard A Klein, John M Reno, David J Grainger, James C Metcalfe, Peter L Weissberg, Peter G Anderson: Therapeutic inhibitor of vascular smooth muscle cells. NoeRx Corporation, Schwegman Lundberg Woessner & Kluth P A, June 13, 2000: US06074659 (263 worldwide citation)

Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a ce ...


4
Lawrence L Kunz, Richard A Klein, John M Reno, David J Grainger, James C Metcalfe, Peter L Weissberg, Peter G Anderson: Therapeutic inhibitor of vascular smooth muscle cells. NeoRx Corporation, Schwegman Lundberg Woessner & Kluth P A, September 22, 1998: US05811447 (221 worldwide citation)

Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a ce ...


5
Lawrence L Kunz, Richard A Klein, John M Reno: Therapeutic inhibitor of vascular smooth muscle cells. SciMed Life Systems, Pennie & Edmonds, April 13, 2004: US06720350 (108 worldwide citation)

Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a ...


6
Lawrence L Kunz, Richard A Klein: Therapeutic inhibitor of vascular smooth muscle cells. NeoRx Corporation, Schwegman Lundberg Woessner & Kluth P A, February 4, 2003: US06515009 (99 worldwide citation)

Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a ce ...


7
Lawrence L Kunz, Richard A Klein: Therapeutic inhibitor of vascular smooth muscle cells. NeoRx Corporation, Schwegman Lundberg Woessner & Kluth P A, July 29, 2003: US06599928 (59 worldwide citation)

Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically effective dosage of a therapeutic conjugate containing a vascular smooth muscle binding protein that associates in a specific manner with a ce ...


8
Lawrence L Kunz, Richard A Klein, John M Reno: Therapeutic inhibitor of vascular smooth muscle cells. NeoRx Corporation, Schwegman Lundenberg Woessner & Kluth PA, March 19, 2002: US06358989 (50 worldwide citation)

Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a ...


9
Richard A Klein: Lift container and method for using same. Harsco Corporation, A Thomas S Safford, March 29, 1988: US04733896 (9 worldwide citation)

A unique lift container for use in erecting scaffolding within power boilers and similar large enclosures having small access manholes, preferably being made from modularized forming equipment so as to be readily disassembled into constituent parts dimensioned to fit through the small access opening ...


10